Diabetic peripheral neuropathic pain Trials in Orlando, United States
Conditions / Diabetic peripheral neuropathic pain / Orlando, United States
Diabetic peripheral neuropathic pain has been the subject of sustained clinical investigation across multiple research sites.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04476108 | Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain | COMPLETED | PHASE2 |
| NCT05177094 | Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain | COMPLETED | PHASE2 |
| NCT05620576 | A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05). | COMPLETED | PHASE2 |
| NCT06628908 | Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy | RECRUITING | — |
| NCT07231419 | Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy | RECRUITING | — |
| NCT00838799 | Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain | COMPLETED | PHASE2 |
| NCT06203002 | A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) | COMPLETED | PHASE2 |
| NCT06696443 | Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06628908 | Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy | RECRUITING | — |
| NCT04707157 | Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain | TERMINATED | PHASE2 |